Two Patients with Arterial Thromboembolism among 311 Patients with Adenocarcinoma of the Pancreas

Effective surgical treatment for controlling the acute heart failure induced by acutely progressed mitral regurgitation with nonbacterial thrombotic endocarditis

“…However, acute arterial thromboembolism in cancer patients is less often recognized. Schattner et al reported that only 2 of 311 autopsy cases of pancreatic adenocarcinoma demonstrated evidence of arterial thromboembolism [12]. This pathological condition seems more often to be a terminal or pre-terminal stage as demonstrated in our case.…”

Incidence and Frequency of Vascular Events in Oncology Patients in Qena University Hospital

“…Regarding arterial events, Schattner concluded that arterial thrombosis is a terminal event in pancreatic cancer patients [19]. In ElSakka's study half of the cancer patients with arterial thrombosis died within six months [20] and this is comparable with our study as in our cancer patients associated with arterial thrombosis 4 patients with acute limb ischemia out of 15 patients (nearly one third) died within treatment course and this indicates the bad prognosis of cancer patients associated with arterial thrombosis while the rest 60 patients with arterial events survive during the follow up period and death happened due to the cancer process itself in many cases.…”

“…But there are two studies regarding arterial thrombosis in cancer patients. The first one searched at a series of 311 pancreatic adenocarcinoma patients, two (0.006%) of whom developed arterial thrombosis [19]. While in the second, 192 patients presenting over 18 months with critical limb ischaemia (CLI) were evaluated and scanned for markers of hidden malignancy [20].…”

“…Regarding arterial thrombosis, few cases in the literature were reported. In one study which included 311 patients with pancreatic cancer, only two patients (0.006%) developed arterial thrombosis [19]. In a second study, 192 patients presenting over a period of 1.5 year with critical limb ischaemia (CLI) were examined and investigated for occult malignancy markers [20].…”

Optimal management of venous thromboembolism in advanced pancreatic cancer with low-molecular-weight heparin: current evidence

“…[8][9][10][11] Cancer therapy (surgery, chemotherapy, and hormonal therapy) serves as an additional risk factor for developing VTE. According to a retrospective analysis of the Prophylaxis of Thromboembolism During Chemotherapy (PROTECHT) study, 12 in the absence of thrombophylaxis, the highest risk of thrombosis is seen in patients receiving gemcitabine (8.1%) or cisplatin-based chemotherapy (7%).…”